Medical News

RSS

CTMS solutions provider TranSenda International acquired by BioClinica

BioClinica™, Inc.,, a global provider of clinical trial management services, today announced its acquisition of substantially all of the assets of privately held TranSenda International, LLC. Headquartered in Bellevue, WA, TranSenda is a provider of clinical trial management software (CTMS) solutions and is a Microsoft Gold Certified Partner.

From Clario 26 Mar 2010

Ontario nurses welcome 1.5% increase in hospital funding

Ontario nurses welcome the 1.5 per cent increase in hospital funding outlined in the Ontario budget, and say this means government and employers must now fast track the promised 9,000 additional nurses to ensure patients receive the quality care they need and deserve.

26 Mar 2010

First Edition: March 26, 2010

Today's early morning highlights includes reports on congressional passage of the final piece of the health overhaul legislation, President Barack Obama's trip to Iowa to tout the law's benefits and some concerns raised by big business.

26 Mar 2010

Informing young women surviving breast cancer about opportunities to have children

At a time when more and more young women are surviving breast cancer and delaying childbirth, it is important to take their needs and wishes about their future fertility into consideration when deciding on treatment, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today.

26 Mar 2010

Dell unveils Medical Archiving and PowerEdge C 6100 solutions to boost healthcare efficiency

Dell today unveiled solutions to enable healthcare, higher-education and government organizations to better use technology to manage data, conduct research and fulfill their missions in a more efficient and secure manner.

26 Mar 2010

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research.

26 Mar 2010

Most transplant candidates agree to receive kidney from donor at increased risk of viral infection

Most kidney transplant candidates are willing to receive a kidney from a donor at increased risk of viral infection, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology. The results suggest that kidney disease patients can make rational tradeoffs between the virtues and risks conferred by donated kidneys.

26 Mar 2010

Final healthcare votes: Congressman Chaka Fattah releases statement

"However you keep time – almost a century since healthcare legislation was first proposed, 17 years since contentious debate began in the Congress, 16 months since President Obama won landslide election on the mandate of healthcare reform, and a climactic week of late-night votes -- we can finally say: the time is NOW for the reality of reform to begin.

26 Mar 2010

Practical strategies to make Ontario's health care system better and more sustainable

The importance of bending the cost curve for Ontario's health care sector has long been top of mind for health system leaders. After all, improving the quality and efficiency of patient care can lead to better value-for-money for taxpayers.

26 Mar 2010

Genentech, Biogen Idec file declaratory relief complaint against GSK regarding Arzerra

Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).

26 Mar 2010

Fairbanks Institute for Healthy Communities introduces INbank biorepository

The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, announced today the creation of INbank™, a next generation biorepository that will provide scientists with an important resource for research on chronic diseases of aging.

26 Mar 2010

Adjuvant systemic must be considered for treatment of primary breast cancer and recurrence

Recurrence of breast cancer in the same area as the original tumour remains the strongest, independent prognostic factor for subsequent metastasis and death, even for patients who have been free of disease for a very long time, according to research presented today (Wednesday) at the seventh European Breast Cancer Conference (EBCC7).

26 Mar 2010

New book on using informatics to reduce healthcare costs to be released

A topical new book about using informatics to reduce healthcare costs edited by Stephan Kudyba, an assistant professor in the NJIT School of Management, will be released early this May. Healthcare Informatics: Improving Efficiency and Productivity addresses the incorporation of information technologies and information management by healthcare providers to increase the efficiencies of their operations to help reduce costs.

26 Mar 2010

New CONSORT statement to improve reporting of trial findings published

New guidance to improve the reporting of trial findings is published simultaneously today (24 March 2010) by PLoS Medicine and eight other leading journals around the world, BMJ, The Lancet, Obstetrics & Gynecology, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.

26 Mar 2010

Roche NimbleGen' s microarray technologies help identify genes responsible for CRC

In a recently published study in the journal Genome Research, a team of scientists led by Dr. Shaying Zhao at the University of Georgia have developed a novel cross-species comparative genomics and oncology strategy for cancer driver gene discovery, using microarray technologies from Roche NimbleGen, that differs fundamentally from current approaches which focus on human cancers only.

26 Mar 2010

Bevacizumab/paclitaxel/carboplatin regimen attains gold-standard status for treatment of non-small-cell lung cancer

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the bevacizumab (Genentech/Roche/Chugai's Avastin)/paclitaxel (Bristol-Myers Squibb's Taxol, generics)/carboplatin (Bristol-Myers Squibb's Paraplatin, generics) regimen will remain Decision Resources' proprietary clinical gold standard for the treatment of advanced non-small-cell lung cancer through 2018.

26 Mar 2010

Educating African Americans on colorectal cancer screening can reduce death rates

Physician experts from the American College of Gastroenterology raised concern that the majority of African Americans are not aware of the recommendation that they should undergo colorectal cancer screening beginning at age 45—five years before current guidelines generally recommend.

26 Mar 2010

Complex relation between breastfeeding, prolactin and breast cancer

Women who are diagnosed with breast cancer in the 12 months after they have completed a pregnancy are 48% more likely to die than other young women with breast cancer according to new research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).

26 Mar 2010

RXi Pharmaceuticals to present advances in RNAi therapeutics at 3rd International Scar Club Meeting

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), announced that Pamela Pavco, Ph.D., Vice President of Pharmaceutical Development, will be presenting at the 3rd International Scar Club Meeting in Montpellier, France on March 26, 2010.

26 Mar 2010

Two separate articles describing preclinical data of ACE-041 published

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, announced the publication of two separate peer-reviewed articles describing preclinical data demonstrating that treatment with ACE-041, an inhibitor of signaling through the activin receptor-like kinase 1 receptor, slows tumor growth and progression by inhibiting angiogenesis.

26 Mar 2010

Medical News

CTMS solutions provider TranSenda International acquired by BioClinica

Ontario nurses welcome 1.5% increase in hospital funding

First Edition: March 26, 2010

Informing young women surviving breast cancer about opportunities to have children

Dell unveils Medical Archiving and PowerEdge C 6100 solutions to boost healthcare efficiency

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Most transplant candidates agree to receive kidney from donor at increased risk of viral infection

Final healthcare votes: Congressman Chaka Fattah releases statement

Practical strategies to make Ontario's health care system better and more sustainable

Genentech, Biogen Idec file declaratory relief complaint against GSK regarding Arzerra

Fairbanks Institute for Healthy Communities introduces INbank biorepository

Adjuvant systemic must be considered for treatment of primary breast cancer and recurrence

New book on using informatics to reduce healthcare costs to be released

New CONSORT statement to improve reporting of trial findings published

Roche NimbleGen' s microarray technologies help identify genes responsible for CRC

Bevacizumab/paclitaxel/carboplatin regimen attains gold-standard status for treatment of non-small-cell lung cancer

Educating African Americans on colorectal cancer screening can reduce death rates

Complex relation between breastfeeding, prolactin and breast cancer

RXi Pharmaceuticals to present advances in RNAi therapeutics at 3rd International Scar Club Meeting

Two separate articles describing preclinical data of ACE-041 published

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News